| 000 | 01684 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516113347.0 | ||
| 264 | 0 | _c20130204 | |
| 008 | 201302s 0 0 eng d | ||
| 022 | _a1532-8600 | ||
| 024 | 7 |
_a10.1016/j.metabol.2012.08.017 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCosta e Silva, Jorge A | |
| 245 | 0 | 0 |
_aPersonalized medicine in psychiatry: new technologies and approaches. _h[electronic resource] |
| 260 |
_bMetabolism: clinical and experimental _cJan 2013 |
||
| 300 |
_aS40-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntidepressive Agents _xmetabolism |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xmetabolism |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2D6 _xgenetics |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
| 650 | 0 | 4 | _aDNA Copy Number Variations |
| 650 | 0 | 4 | _aDiffusion Tensor Imaging |
| 650 | 0 | 4 | _aElectroencephalography |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHippocampus _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMagnetoencephalography |
| 650 | 0 | 4 |
_aMental Disorders _xdiagnosis |
| 650 | 0 | 4 |
_aNerve Net _xphysiopathology |
| 650 | 0 | 4 |
_aNeuroimaging _xmethods |
| 650 | 0 | 4 |
_aPharmacogenetics _xmethods |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 |
_aPrecision Medicine _xmethods |
| 650 | 0 | 4 |
_aPrefrontal Cortex _xdrug effects |
| 650 | 0 | 4 |
_aPsychiatry _xmethods |
| 650 | 0 | 4 |
_aPsychotropic Drugs _xmetabolism |
| 773 | 0 |
_tMetabolism: clinical and experimental _gvol. 62 Suppl 1 _gp. S40-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.metabol.2012.08.017 _zAvailable from publisher's website |
| 999 |
_c22141184 _d22141184 |
||